Sign In

The AASLD Liver Meeting 2017, Washington DC, October 20-24

21st Century Hepatology: Translating Discoveries into Practice

Date/Time

  • Saturday, October 21, 8 am–5:15 pm

Program Chairs

  • Ronald J. Sokol, MD, FAASLD
  • K. Rajender Reddy, MD, FAASLD
  • Mary E. Rinella, MD, FAASLD

Continuing Education Information

  • CME – 6.75 AMA PRA Category 1 Credits™
  • MOC - 6.75 Hours
  • ABP MOC - 1.5 hours
  • CE - 6.75 Hours

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Understand evidence-based evaluation and management options available for a spectrum of liver problems and the benefits and risks of each approach.
  • Be better informed to make rational decisions for optimal management of patients and engage patients in shared-decision making.
  • Incorporate new emerging knowledge and evidence into practice of hepatology.

Session Description/Needs Statement

Now, more than ever, hepatologists and hepatology health professionals must guide personalized treatment plans for their patients. 21st Century Hepatology will help you do just that by discussing new and best evidence, therapeutic advances, and breakthroughs on the horizon. From the application of biomarkers to genetics and lifestyle, this course offers a state-of-the art look at translating discoveries into modern-day hepatology practice.

Session I: Hepatitis Module

Moderators: Norah Terrault MD, MPH, FAASLD and Raymond T. Chung MD, FAASLD

  • 8-8:05 am
    Welcome and Introduction
    Ronald J. Sokol MD, FAASLD
  • 8:05-8:25 am
    Autoimmune Hepatitis – New Pathways and Therapeutic Strategies
    Michael P. Manns, MD
  • 8:25-8:45 am
    Innovative Strategies To Cure and Eradicate Hepatitis B in the 21st Century
    Marc G. Ghany, MD, FAASLD
  • 8:45-9:05 am
    Hepatitis C: Can We Translate A Cure into Real-world Practice?
    David R. Nelson, MD

Session II: Steatohepatitis Module

Moderators: Mary E. Rinella, MD, FAASLD and Vijay  Shah, MD

  • 9:05-9:25 am
    Role of Gut-liver Axis in Obesity and Fatty Liver
    Jasmohan S. Bajaj, MD, FAASLD
  • 9:25-9:45 am
    Enduring Role of Liver Biopsy in Diagnosis and Assessment of Therapeutic Response
    David Kleiner, MD, PhD
  • 9:45-10:05 am
    NASH – Imaging and Serum Biomarkers in Treatment Decisions in NASH
    Rohit Loomba, MD
  • 10:05-10:25 am
    NASH – Current and Emerging Therapies
    Quentin M. Anstee, MBBS, PhD
  • 10:25- 10:45 am
    Alcoholic Liver Disease: Confronting an Old Foe with New Treatments
    Gyongyi Szabo, MD, PhD, FAASLD
  • 10:45-11:10 am
    Break

Session III: Liver and Biliary Cancer Module

Moderators: Julie Heimbach, MD, FAASLD and Elizabeth M. Brunt, MD, FAASLD

  • 11:10-11:30 am
    Screening for Hepatobiliary Neoplasia – Where are We Now?
    Hashem B. El-Serag, MD, MPH
  • 11:30-11:50 am
    Advances in the Diagnosis of Hepatobiliary Neoplasia
    Jorge A. Marrero, MD
  • 11:50 am-12:10 pm
    Individualizing Treatment in Hepatobiliary Neoplasia
    Laura M. Kulik, MD
  • 12:10 -12:30 pm
    Evolving Role of Liver Transplantation in Hepatobiliary Neoplasia
    Francis Yao, MD
  • 12:30-2:00 pm
    Intermission – Meet-the-Professor Luncheons (Clinical)
    *Ticketed Session

Session IV: Cholestatic, Genetic and Drug-induced Liver Diseases Module

Moderators: Michael H. Trauner, MD, FAASLD and Cara L. Mack, MD

  • 2-2:20 pm
    Therapeutic Advances in Adult Cholestatic Liver Diseases
    Cynthia Levy, MD, FAASLD
  • 2:20-2:40 pm
    Pediatric Cholestatic Liver Diseases: Advances in Diagnosis and Management
    Jorge A. Bezerra, MD, FAASLD
  • 2:40-3 pm
    Drug-induced Liver Diseases – Paradigms for Identification and Management
    Guruprasad P. Aithal, MD, PhD
  • 3-3:30 pm
    Break

Session V: Challenges in Advanced Liver Disease Management

Moderators: Lopa  Mishra, MD, FAASLD and K. Rajender  Reddy, MD, FAASLD

  • 3:30-3:50 pm
    Optimizing Outcomes in the Deconditioned Cirrhotic
    Jennifer C. Lai, MD
  • 3:50-4:10 pm
    Diagnosis and Management of Kidney Injury: From Urinalysis to Proteomics
    Paolo Angeli, MD, PhD
  • 4:10-4:30 pm
    Coagulation Derangements in Cirrhosis – A New Paradigm
    R. Todd Stravitz, MD, FAASLD
  • 4:30-4:50 pm
    Bridging Acute or Acute-on-Chronic Liver Failure Patient to Transplant
    Jacqueline G. O’Leary, MD, MPH
  • 4:50-5:10 pm
    New Strategies for Managing Portal Hypertension and its Manifestations
    Guadalupe Garcia-Tsao, MD, FAASLD
  • 5:10-5:15 pm
    Wrap Up
    Ronald J. Sokol, MD, FAASLD